about
[Role of myostatin in wasting syndrome associated with chronic diseases].Limited value of cystatin-C over estimated glomerular filtration rate for heart failure risk stratification.First-in-man Safety and Efficacy of the Adipose Graft Transposition Procedure (AGTP) in Patients With a Myocardial Scar.Weight Loss in Obese Patients With Heart Failure.Impact of diabetes on the predictive value of heart failure biomarkers.Development of a novel heart failure risk tool: the barcelona bio-heart failure risk calculator (BCN bio-HF calculator).Multimarker Strategy for Heart Failure Prognostication. Value of Neurohormonal Biomarkers: Neprilysin vs NT-proBNP.Prognostic Value and Kinetics of Soluble Neprilysin in Acute Heart Failure: A Pilot Study.No benefit from the obesity paradox for diabetic patients with heart failure.Wearable vest for pulmonary congestion tracking and prognosis in heart failure: A pilot study.The real-life value of ST2 monitoring during heart failure decompensation: impact on long-term readmission and mortality.Biomarker-assist score for reverse remodeling prediction in heart failure: The ST2-R2 score.Aging and Heart Rate in Heart Failure: Clinical Implications for Long-term Mortality.Fragility is a key determinant of survival in heart failure patients.Combined use of the novel biomarkers high-sensitivity troponin T and ST2 for heart failure risk stratification vs conventional assessment.Head-to-head comparison of 2 myocardial fibrosis biomarkers for long-term heart failure risk stratification: ST2 versus galectin-3.Estimated glomerular filtration rate and prognosis in heart failure: value of the Modification of Diet in Renal Disease Study-4, chronic kidney disease epidemiology collaboration, and cockroft-gault formulas.Estimated creatinine clearance: a determinant prognostic factor in heart failure.[Prognostic significance of creatinine clearance rate in patients with heart failure and normal serum creatinine].[Does body mass index influence mortality in patients with heart failure?].Head-to-head comparison of high-sensitivity troponin T and sensitive-contemporary troponin I regarding heart failure risk stratification.Effect of fragility on quality of life in patients with heart failure.Soluble neprilysin is predictive of cardiovascular death and heart failure hospitalization in heart failure patients.Recovered heart failure with reduced ejection fraction and outcomes: a prospective study.Renal function largely influences Galectin-3 prognostic value in heart failure.Long-term prognostic value for patients with chronic heart failure of estimated glomerular filtration rate calculated with the new CKD-EPI equations containing cystatin C.[An unusual case of transmural calcifying inflammatory pseudotumor of the heart].Body mass index, body fat, and nutritional status of patients with heart failure: The PLICA study.Autoimmunity and Atrioventricular Block of Unknown Etiology in AdultsSoluble ST2 Serum Concentration and Renal Function in Heart FailureThe obesity paradox in heart failure: Is etiology a key factor?Myostatin serum levels in heart failureCirugía coronaria con mini-circulación extracorpórea: experiencia de un grupo en EspañaOsteosarcoma in left atrium treated with autotransplantRespuestaValoración clínica, ecocardiográfica y pronóstica de la fibrilación auricular en pacientes con insuficiencia cardíacaUnidades de insuficiencia cardiaca en España: situación actualDiámetro de la aurícula izquierda: un parámetro ecocardiográfico sencillo con importante significado pronóstico en la insuficiencia cardíacaSeudorreestenosis de stent por anillo de calcio
P50
Q33392791-2939B4FA-5A77-430F-9105-2389AA1C6788Q34512274-91EF0D02-FF3E-4B1E-8156-07295FD96F84Q37008464-1FC70F74-0EDE-470C-9E93-B91AB6C560B3Q37090681-23653199-2ECA-4BC2-8744-9EE8F97C926DQ37390778-D08AF924-6ED0-4F2D-8A96-F9284802884EQ37484132-D2D14965-7A3B-4658-9FEB-781C2466AF12Q40617959-C3AA89CD-74AF-4E78-981D-F4A7299DD809Q40649865-EF1AEDD7-0AF4-4679-B89C-CAFFAAB1C72FQ40696102-691FEADE-B00F-4A2C-841F-361FD5C6C10EQ40783400-C3B7219E-307E-4989-97D1-66227895C5F4Q40976941-3084C850-5562-4A22-B6AC-DF00E1D39694Q41311637-171B6425-2595-4DC5-B3E3-1EDDDE98D26FQ41691774-67D58E9B-CF11-4933-AEAA-0AAF07A39051Q43509121-BDC2A89B-B000-4EA9-9024-E68584A98985Q43719505-F0EF69CA-045A-4CF9-A27E-96FCBF7A7FFFQ44118879-00DE377B-A94E-430B-B47D-CA903E5AFECEQ44559776-655A039D-952B-4EE1-953A-24A904F7B0EDQ46511884-77E3A2F6-B127-4AF2-97C6-5B00C6C69C6CQ46848920-ADDDE0E3-BD70-4122-B6BB-52868B8C1FA5Q46905061-7C93869B-4936-4FB0-B14D-F55939FA6C31Q47697065-8A468A5A-0311-409A-8DE9-5C8B087133D7Q48174192-65A12B5C-C032-4D8D-BDA3-30571C861786Q48331571-6E9FFA64-21ED-4E4D-B351-F02B3216B1A5Q50926906-515DD7FB-30BA-4846-AD0A-FEF0A97D002DQ50995380-F3A10897-A16E-4A45-8C99-B5547E2CF6F3Q51139931-6C99F201-CEA5-4E6D-9B1C-A3348C27617DQ53230325-FB3F0577-7A84-43C8-9DB8-EF741C1E3570Q53968806-B2D069BB-3FFE-4C9E-8351-73BFA70D2D36Q60638725-103A48C1-7846-481A-BCFA-5C195994A24FQ60638746-AC067F64-D44A-4C1E-B312-6660AFF2E852Q60638751-1A5037F0-F94C-4626-BBC1-5FF681EC4100Q60638768-CC816A49-891D-4B7F-BA6F-5C501DF831E4Q60638789-05D2360D-6606-487E-A36E-6B21E161BF5EQ60638797-1B72D929-3311-490C-BB8B-6DCC411CB902Q60638806-8A3939AB-841F-4321-AA36-B47D481A0C09Q60638814-03D21265-CFE7-46A0-AD12-7B173CB13917Q60638816-5D8571CF-6A9F-4F97-80F7-4EB0D337A898Q60638817-D5567863-4A6B-4580-9320-DAA5DC36DF84Q60638818-E2F095A0-CFAA-42EA-9EFA-320C7A929F13
P50
description
hulumtuese
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Elisabet Zamora
@ast
Elisabet Zamora
@en
Elisabet Zamora
@es
Elisabet Zamora
@fr
Elisabet Zamora
@nl
Elisabet Zamora
@sl
type
label
Elisabet Zamora
@ast
Elisabet Zamora
@en
Elisabet Zamora
@es
Elisabet Zamora
@fr
Elisabet Zamora
@nl
Elisabet Zamora
@sl
prefLabel
Elisabet Zamora
@ast
Elisabet Zamora
@en
Elisabet Zamora
@es
Elisabet Zamora
@fr
Elisabet Zamora
@nl
Elisabet Zamora
@sl
P106
P1153
22837393800
P21
P31
P496
0000-0001-5317-7481